Technical Analysis for NRSNW - NeuroSense Therapeutics Ltd. - warrant
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
Crossed Above 50 DMA | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze Started | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Fell Below 50 DMA | Bearish | 2.60% | |
20 DMA Support | Bullish | 2.60% | |
Wide Bands | Range Expansion | 2.60% | |
Gapped Down | Weakness | 2.60% |
Alert | Time |
---|---|
Reversed from Down | 2 days ago |
20 DMA Support | 2 days ago |
10 DMA Support | 2 days ago |
Rose Above 50 DMA | 2 days ago |
Down 5% | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/01/2022
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Alzheimer's Disease Parkinson's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Treatment Of Parkinson's Disease Senescence Neurodegenerative Disease Treatment Of Alzheimer's Disease Clinical Neuroscience
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Alzheimer's Disease Parkinson's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Treatment Of Parkinson's Disease Senescence Neurodegenerative Disease Treatment Of Alzheimer's Disease Clinical Neuroscience
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.55 |
52 Week Low | 0.073 |
Average Volume | 4,032 |
200-Day Moving Average | 0.20 |
50-Day Moving Average | 0.18 |
20-Day Moving Average | 0.16 |
10-Day Moving Average | 0.16 |
Average True Range | 0.04 |
RSI (14) | 52.38 |
ADX | 29.69 |
+DI | 34.03 |
-DI | 25.34 |
Chandelier Exit (Long, 3 ATRs) | 0.13 |
Chandelier Exit (Short, 3 ATRs) | 0.23 |
Upper Bollinger Bands | 0.21 |
Lower Bollinger Band | 0.11 |
Percent B (%b) | 0.66 |
BandWidth | 62.88 |
MACD Line | 0.00 |
MACD Signal Line | -0.01 |
MACD Histogram | 0.0035 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.27 | ||||
Resistance 3 (R3) | 0.26 | 0.22 | 0.25 | ||
Resistance 2 (R2) | 0.22 | 0.20 | 0.23 | 0.25 | |
Resistance 1 (R1) | 0.20 | 0.19 | 0.18 | 0.21 | 0.24 |
Pivot Point | 0.17 | 0.17 | 0.16 | 0.17 | 0.17 |
Support 1 (S1) | 0.14 | 0.14 | 0.12 | 0.15 | 0.11 |
Support 2 (S2) | 0.11 | 0.13 | 0.11 | 0.11 | |
Support 3 (S3) | 0.08 | 0.11 | 0.10 | ||
Support 4 (S4) | 0.09 |